Related Experiment Videos

Ascending aortic hemodynamics and one-year clinical events following percutaneous coronary intervention

Robert E Eckart1, Dale Yoo, Eric A Shry

  • 1Cardiology Division, Brooke Army Medical Center, San Antonio, TX 78234-6200, USA.

The Journal of Invasive Cardiology
|October 27, 2004
PubMed

Insights

Increased pulse pressure (PP) may predict mortality, but this study found no significant link between PP and cardiac events after percutaneous coronary stenting. Aortic PP did not predict 1-year risk for major adverse cardiac events (MACE).

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Increased pulse pressure (PP) is a known predictor of mortality and major adverse cardiac events (MACE) in ambulatory patients.
  • Previous reports suggest a potential link between elevated PP and worse outcomes after percutaneous coronary balloon angioplasty.

Purpose of the Study:

  • To investigate the association between pulse pressure (PP) and pulse pressure fraction (PPf) with clinical outcomes in patients undergoing percutaneous coronary intervention with stenting.
  • To determine if PP or PPf predicts 1-year MACE following coronary stenting.

Main Methods:

  • A retrospective review of 434 patients who underwent percutaneous coronary stenting.
  • Analysis of clinical outcomes, including death, myocardial infarction, and revascularization, at 1 year post-procedure.
  • Assessment of PP and PPf as potential predictors of these outcomes.

Main Results:

  • Major adverse cardiac events (MACE) occurred in 17.9% of the study cohort within 1 year.
  • No statistically significant difference in PP or PPf was observed between patients with and without adverse cardiac events.
  • Neither PP nor PPf demonstrated predictive value for 1-year MACE in this stenting cohort.

Conclusions:

  • Aortic pulse pressure at the time of percutaneous coronary intervention with stenting does not appear to predict the risk for cardiac events at 1 year.
  • Findings contrast with previous reports linking PP to outcomes after balloon angioplasty, suggesting a different risk profile for stenting procedures.
  • Further research may be warranted to fully elucidate the role of PP in the context of modern interventional cardiology.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...